Description

Olanzapine Tablets (2.5 mg / 5 mg / 7.5 mg / 10 mg / 15 mg)

Healthy Inc is a globally recognized supplier of advanced neuropsychiatric solutions. We provide premium Olanzapine Tablets, available in both film-coated and Orally Disintegrating (ODT) formulations, manufactured in WHO–GMP certified specialized psychotropic units. As a primary therapy for complex mood disorders, this product is a cornerstone export for psychiatric hospitals, rehabilitation centers, and National Health Tenders in Southeast Asia, Africa, and the CIS region.

Product Overview

Olanzapine is a second-generation (atypical) antipsychotic belonging to the thienobenzodiazepine class. It is specifically engineered to treat a broad spectrum of psychiatric conditions by modulating multiple neurotransmitter systems, offering superior efficacy in managing both positive and negative symptoms of psychosis.

The “Multi-Receptor” Neuroleptic Specialist:

• Synergistic Receptor Affinity: Olanzapine exhibits a broad pharmacological profile, acting as an antagonist at Dopamine (D1, D2, D3, D4), Serotonin (5-HT2A, 5-HT2C, 5-HT3), Muscarinic (M1-M5), and Histamine (H1) receptors. This multi-target approach is key to its high therapeutic index.
• Mood Stabilization: Beyond its antipsychotic properties, Olanzapine acts as a potent mood stabilizer, making it highly effective for the acute treatment of manic or mixed episodes in Bipolar I Disorder.
• Low Extrapyramidal Risk: Due to its preferential action on the mesolimbic pathway over the nigrostriatal pathway, it carries a significantly lower risk of motor side effects (EPS) compared to first-generation antipsychotics.

Technical & Manufacturing Specifications

Formulated for precise release kinetics and molecular integrity.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from specialized ISO 9001:2015 units.

• Polymorph Stability: Olanzapine is prone to polymorphic transitions. Our manufacturing process ensures the stability of Form I, providing consistent dissolution and predictable plasma concentrations ($C_{max}$).
• ODT Technology: Our Orally Disintegrating Tablets utilize freeze-drying or advanced compression technology to dissolve in seconds without water, ensuring rapid onset and preventing “cheeking” in non-compliant patients.
• Stringent Impurity Profiling: We maintain strict controls on related substances and residual solvents, ensuring a safety profile that meets stringent international regulatory standards.

Therapeutic Indications & Clinical Symptoms

• Schizophrenia: Treatment of acute psychosis and maintenance of clinical improvement during continuation therapy.
• Bipolar I Disorder: Treatment of acute manic or mixed episodes and prevention of recurrence in patients who have responded to olanzapine.
• Treatment-Resistant Depression: Used in combination with Fluoxetine for patients who do not respond to standard antidepressants.
• Agitation: Rapid control of acute agitation associated with schizophrenia and bipolar mania.

Dosage & Administration

• Dosing Range: Typically 5 mg to 20 mg once daily. Dosage is titrated based on clinical response and tolerability.
• Administration: Can be taken with or without food. ODT tablets should be placed on the tongue to dissolve.
• Metabolic Monitoring: Clinical observation for weight gain, hyperglycemia, and hyperlipidemia is recommended during long-term therapy.

Global Export & Contract Manufacturing Services

Healthy Inc is a verified Pharmaceutical Exporter in Mumbai, catering to Mental Health Institutions and Ministry of Health Tenders. We offer Third Party Manufacturing for Olanzapine with full CTD Dossier and COPP support. Our logistics network ensures secure transit to Vietnam, Nigeria, Philippines, and the CIS region, providing WHO-GMP quality at competitive B2B prices.

Commercial Inquiries

WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in